Internal Group Restructuring via Subsidiary Disposal
씨엑스아이
900120
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
55%n=166
Risk-adjusted indicator based on 166 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Disposal Amount: 313,153,708,470 KRW
- • Disposal Amount to Consolidated Assets: 63.37%
- • Subsidiary Capital: 1,891,600,000 KRW
- • Subsidiary Assets: 111,719,236,766 KRW (22.61% of consolidated assets)
- • Disposal Date: August 31, 2026
AI Analysis Summary
CXI Healthcare Technology Group Limited decided to dispose of shares in Zhejiang Jingsheng Health Technology Group Co., Ltd. for 313,153,708,470 KRW, representing 63.37% of consolidated assets. This is an internal, non-cash transfer aimed at simplifying the governance structure and improving management efficiency within the same consolidated group. Post-transaction, the parent company will directly hold 100% of the shares of Fujian Yongsheng Vitality Bioengineering Co., Ltd., which was previously a sub-subsidiary. The transaction involves no cash flow and is primarily for organizational restructuring.
How This Event Is Evaluated
Treasury Share Disposal Evaluation
Treasury share disposal events are evaluated by assessing supply impact, disposal method, and stated purpose.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Disposal size relative to shares outstanding
- Disposal method and timing
- Stated purpose (funding, compensation, etc.)
- Dilution / supply impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.